Anthony Mack
2023
In 2023, Anthony Mack earned a total compensation of $1.2M as Former Chief Executive Officer, Chairman at Virpax Pharmaceuticals, a 55% increase compared to previous year.
Compensation breakdown
| Option Awards | $60,000 |
|---|---|
| Salary | $445,000 |
| Other | $711,000 |
| Total | $1,216,000 |
Mack received $711K in other compensation, accounting for 58% of the total pay in 2023.
Mack also received $60K in option awards and $445K in salary.
Rankings
In 2023, Anthony Mack's compensation ranked 1,004th out of 3,006 executives tracked by ExecPay. In other words, Mack earned more than 66.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,004 out of 3,006 | 67th |
Division Manufacturing | 597 out of 1,650 | 64th |
Major group Chemicals And Allied Products | 409 out of 918 | 55th |
Industry group Drugs | 398 out of 881 | 55th |
Industry Pharmaceutical Preparations | 270 out of 637 | 58th |
Source: SEC filing on December 9, 2024.
Mack's colleagues
We found four more compensation records of executives who worked with Anthony Mack at Virpax Pharmaceuticals in 2023.